4MLX image
Entry Detail
PDB ID:
4MLX
Keywords:
Title:
Structure of a bidentate 3-hydroxy-4H-pyran-4-thione ligand bound to hCAII
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2013-09-06
Release Date:
2014-07-02
Method Details:
Experimental Method:
Resolution:
1.65 Å
R-Value Free:
0.20
R-Value Work:
0.15
R-Value Observed:
0.15
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Carbonic anhydrase 2
Chain IDs:A
Chain Length:260
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
'Unconventional' coordination chemistry by metal chelating fragments in a metalloprotein active site.
J.Am.Chem.Soc. 136 5400 5406 (2014)
PMID: 24635441 DOI: 10.1021/ja500616m

Abstact

The binding of three closely related chelators: 5-hydroxy-2-methyl-4H-pyran-4-thione (allothiomaltol, ATM), 3-hydroxy-2-methyl-4H-pyran-4-thione (thiomaltol, TM), and 3-hydroxy-4H-pyran-4-thione (thiopyromeconic acid, TPMA) to the active site of human carbonic anhydrase II (hCAII) has been investigated. Two of these ligands display a monodentate mode of coordination to the active site Zn(2+) ion in hCAII that is not recapitulated in model complexes of the enzyme active site. This unprecedented binding mode in the hCAII-thiomaltol complex has been characterized by both X-ray crystallography and X-ray spectroscopy. In addition, the steric restrictions of the active site force the ligands into a 'flattened' mode of coordination compared with inorganic model complexes. This change in geometry has been shown by density functional computations to significantly decrease the strength of the metal-ligand binding. Collectively, these data demonstrate that the mode of binding by small metal-binding groups can be significantly influenced by the protein active site. Diminishing the strength of the metal-ligand bond results in unconventional modes of metal coordination not found in typical coordination compounds or even carefully engineered active site models, and understanding these effects is critical to the rational design of inhibitors that target clinically relevant metalloproteins.

Legend

Protein

Chemical

Disease

Primary Citation of related structures